Larvol Delta - Cellenkos-Announces-US-FDA-Orphan-Drug-Designation-Granted-to-CK0801-Allogeneic-Cord-Blood-derived-T-regulatory-Cell-Product-for-Treatment-of-Aplastic-Anemia

CK0801 - Cellenkos

https://www.prnewswire.com/news-releases/cellenkos-announces-us-fda-orphan-drug-designation-granted-to-ck0801-allogeneic-cord-blood-derived-t-regulatory-cell-product-for-treatment-of-aplastic-anemia-302427571.html

Apr 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next